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Basic fibroblast growth factor is increasingly implicated in cellular growth, differentiation, angiogenesis and oncogenesis. In culture, basic fibroblast 
growth factor greatly improved the growth rate of bovine brain cortex capillary endothelial cells. Down-regulation of protein kinase C by prolonged 
treatment with phorbol esters prevented the mitogenic effect of basic fibroblast growth factor on capillary endothelial cells. Furthermore, 
staurosporine, apotent protein kinase inhibitor, showed strong antiproliferative activity against basic fibroblast growth factor-induced endothelial 
cell growth. Similarly, the chemotaxis effect of basic fibroblast growth factor on capillary endothelial cells was abolished by down-regulation of 
protein kinase C or by staurosporine treatment. Therefore, it is suggested that protein kinase C could account for part of the angiogenic effect 
of basic fibroblast growth factor. 
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1. INTRODUCTION and by inhibitory effect of staurosporine, a highly po- 
tent inhibitor of PKC [lo]. 
Angiogenesis is a complex process in which capillary 
blood vessels grow in an ordered sequence of events [I]. 
Among the substances that are known to act predomi- 
nantly on capillary proliferation by direct action on 
vascular endothelial cells are peptidic heparin binding 
growth factors of the fibroblast growth factor (FGF) 
family [2]. Although it has been clearly established that 
acidic and basic FGF participate in the regulation of 
angiogenesis, both in vitro [2,3] and vin vivo [4,5], their 
mode of action has not yet been clearly defined. Recent 
work using Swiss 3T3 fibroblasts, suggested that basic 
FGF (bFGF) at mitogenic concentrations activated the 
calcium/phospholipid-dependent protein kinase, pro- 
tein kinase C (PKC) [6,7]. 
As a step towards understanding bFGF signal trans- 
duction in endothelial cells, we have examined the in- 
volvement of PKC in the mitogenic and chemotaxis ef- 
fects of bFGF on bovine cerebral cortex capillary en- 
dothelial cells. 
2. MATERIALS AND METHODS 
2. I. Chemicals 
PKC is a key regulatory enzyme involved in both 
signal transduction and cellular proliferation of various 
cell types (for review see [S]). In a recent paper, we 
demonstrated that the active tumor promoters 12-O-te- 
tradecanoylphorbol-13-acetate (TPA) and phorbol- 
12,13-dibutyrate which activate PKC, greatly improved 
the growth rate of bovine brain cortex capillary en- 
dothelial cells in culture [9] showing that PKC plays a 
fundamental role in capillary endothelial cell growth. 
PKC implication in endothelial cell proliferation was 
further demonstrated by down-regulation experiments 
Tissue culture reagents were from Boehringer Mannheim (France). 
Bovine basic fibroblast growth factor (bFGF) was purchased from 
Amersham (France). 12-O-tetradecanoylphorbol-13-acetate (TPA) 
and 4o-phorbol-12,13_didecanoate w re purchased form Sigma 
(France). Staurosporine was from Fluka (Germany). All other 
chemicals were from Prolabo (France). 
2.2. Cell culture 
Capillary endothelial cells were isolated from bovine cerebral cor- 
tex, cloned and cultured as described by Gospodarowicz et al. [1 11. 
Cells were grown in Dulbecco’s modified Eagle medium sup- 
plemented with 10% foetal calf serum, 4 mM glutamine, 100 U/ml 
penicillin, 100 pg/ml streptomycin sulphate and 1 ng/ml bovine 
pituitary FGF (added every other day) until cultures were confluent. 
Endothelial cell cultures were passaged weekly at a split ratio of 1:4. 
Capillary endothelial cells were identified as vascular endothelial cells 
by the presence of factor VIII-related antigen, as previously described 
1121. 
2.3. Proliferation assays 
Correspondence address: J.M. Herbert, Unite de Biochimie Explora- Cell proliferation assays were performed in fibronectin-coated 
toire, Sanofi Recherche, 19.5 Route d’Espagne, 31036 Toulouse 24-well cluster plates (Nunc, Denmark). Cultures to be grown in 
Cedex, France Dulbecco’s modified Eagle medium with 2% foetal calf serum were 
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seeded (20 x 10’ cells/well) and maintained for the length of the ex- 
periment without change of the media. 6 h after plating of the cells, 
different concentrations of the tested compounds were added. Phor- 
bol esters and staurosporine were solubilized in dimethylsulfoxide. 
bFGF was added every other day. After a S-day period, triplicate 
plates were trypsinized and the cell number was determined using a 
Coulter counter. 
2.4. Chemotaxis assays 
Chemotaxis assays were carried out using a 48-microwell apparatus 
(Neuroprobe, Cabin John, MD) as described [13]. Test solutions in 
Dulbecco’s modified Eagle medium + 0.2% bovine serum albumin 
or control media were loaded into each bottom well. A nucleopore 
membrane with 8 ,um pores from Neuroprobe (Cabin John, MD) was 
appied to the plate. The top plate with upper wells was attached and 
the apparatus was equilibrated at 37°C for 15 min. The cells used in 
the assay were detached from the culture flask by trypsin treatment 
(O.OWo trypsin, 0.02% EDTA). After centrifugation (400 x g, 10 
min) the cells were resuspended inDulbecco’s modified Eagle medium 
+ 10% foetal calf serum (final concentration: lo6 cells/ml). Cell 
suspensions were loaded into each top chamber of the microwell plate 
(50 x 10’ cells/well) and the apparatus was incubated at 37°C with 
5% COZ for 5 h. After disassembling, the non-migrated layer of cells 
was removed from the membrane using a rubber wiper blade 
(Neuroprobe). The migrated cells were fixed to the membrane and 
stained using a M + D Diff quick-staining set (Dade, France). The 
membrane was rinsed with Hz0 and the cells which had migrated were 
counted under a microscope (250 x magnification). Five fields were 
counted for each well and 4 replicate wells were run for each ex- 
perimental protocol. The number of cells per field was converted to 
cells per mm2 (0.8 mm2/field) and averaged. Results were expressed 
as a percentage of migrating cells per total number of cells originally 
placed in each well. 
3. RESULTS AND DISCUSSION 
3.1. Involvement of PKC in the mitogenic effect of 
basic fibroblast growth factor on bovine cerebral 
cortex capillary endothelial cells 
When tested at concentrations ranging from 0.1 to 5 
ng/ml, bFGF greatly improved the proliferation of en- 
dothelial cells (fig.1). The concentration of bFGF re- 
quired to obtain optimal cell proliferation was observed 
to be 1 ng/ml. This result is in general agreement with 
other studies performed on vascular endothelial cells 
from different origins [ 11,141. To investigate the exact 
role of PKC in bFGF-induced capillary endothelial cell 
growth, cells were exposed to 200 nM TPA for 72 h. It 
is now well known that prolonged treatment with phor- 
bol esters leads to down-regulation of intracellular PKC 
[9]. Fig. 1 shows that this preincubation strongly affects 
the mitogenicity of bFGF. rku-phorbol-12,13-dideca- 
noate, known to be inactive for PKC, is without effect 
of bFGF mitogenicity on endothelial cells. In a recent 
paper, we have shown that staurosporine, a microbial 
alkaloid and actually the most potent inhibitor of pro- 
tein kinase [lo], inhibits TPA-induced bovine cerebral 
cortex capillary endothelial cell proliferation [91. 
Therefore, to further demonstrate the fundamental role 
of PKC in bFGF-induced endothelial cell growth, the 
effect of staurosporine was investigated. Incubation of 
endothelial cells with increasing concentrations of 
staurosporine in the presence of either bFGF (1 ng/ml) 
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Fig.1. Effect of bFGF on the growth of capillary endothelial cells, 
effect of TPA preincubation. Confluent endothelial cells in 75 cm’ 
culture flasks were incubated for 72 h in the absence (0) or presence 
(m) of 200 nM TPA. After 3 washes in Dulbecco’s modified Eagle 
medium, cells were trypsinized, seeded into 24-well cluster plates (20 
x 10’ cells/well) and grown in Dulbecco’s modified Eagle medium 
suppemented with 2% foetal calf serum and increasing concentrations 
of bFGF. After 5 days in culture, triplicate wells were trypsinized and 
cells were counted. Data are expressed as mean cell density f SEM. 
or TPA (10 nM) results in strong inhibition of cellular 
growth (fig.2). Half-maximal inhibitory doses (R&O) 
were respectively 0.7 and 1.3 nM indicating in both 
cases that the antiproliferative activity of staurosporine 
against bFGF or TPA mitogenic activity occurs in a 
range of concentrations which corresponds to its known 
inhibitory action of PKC [lo]. 
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Fig.2. Effect of staurosporine on bovine cerebral cortex capillary 
endothelial cell growth. Cells were seeded at 20 x 10” cells/well and 
incubated with increasing concentrations of staurosporine in 
Dulbecco’s modified Eagle medium supplemented with 2% foetal calf 
serum and bFGF (1 ng/ml) (m) or TPA (10 nM) (0). Cell numbers 
were determined after 5 days in culture. Data are expressed as the 
mean of 3 experiments. 
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Fig.3. Effect of TPA preincubation on the chemotactic effect of 
bFGF on bovine cerebral cortex capillary endothelial cells. Increasing 
concentrations of bFGF were analysed for their ability to promote 
endothelial cell migration in the Boyden chamber (see section 2 for 
experimental details). Cells were preincubated for 48 h in the absence 
(e) or presence (=) of TPA (208 nM). Results are expressed as 
percent of migrating cells per total number of cells added in each well 
(50 x ld cells/well). Data are reported as mean f SEM cell number 
for 3 replicate chemotaxis assays. 
3.2. PKC involvement in the chemotuctic response of 
bovine cerebral cortex capillary e~dothe~ia~ cellsto 
basic fibroblast growth factor 
When capillary endothelial cells were placed in the 
upper compartment of a modified Boyden chamber, we 
observed that increased migration occurred with as little 
bFGF as 20 ng/ml in the lower compartment (fig.3). 
The optimal concentration of bFGF for maximum 
chemotaxis was 100 ng/ml. In this model, bFGF was 
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Fig.4. Effect of staurosporine on the chemotaxis response of bovine 
brain cortex capillary endothelial cells to bFGF. Chemotaxis was 
assayed in the modifled Boyden chamber (see section 2 for details). 
Increasing concentrations of staurosporine were incubated with 250 
ngfml bFGF. Results are reported as mean of 3 replicate chemotaxis 
assays. 
5-lo-fold more potent than other well known chemo- 
tactic agents like prostaglandin-El or fibrinogen (not 
shown). Furthermore, capillary endothelial cells proved 
to be more sensitive to bFGF than bovine aortic en- 
dothelial cells or human umbilical vein endothelial cells 
[14]. To determine the true contribution of PKC in the 
chemotactic effect of bFGF, endothelial cells were 
exposed to 200 nM TPA for 48 h and tested for their 
ability to migrate in response to bFGF. Under these 
conditions, bFGF showed slight migratory activity but 
maximal migration was 5-fold lower than in controls, 
indicating that loss of intracellular PKC leads to strong 
inhibition of the chemotactic effect of bFGF. Similarly, 
staurosporine inhibited the migration of endothelial 
cells in a concentration-dependent manner (I& = 8 
nM) (fig.4). 
Therfore, although the precise role played by bFGF 
in angiogenesis is not easily predicted by in vitro ex- 
periments, it is likely that its effect on capillary growth 
is mediated in part through activation of PKC. This is 
further supported by previous work showing that ap- 
plication of phorbol esters to microvessels mimics some 
of the events involved in angiogenesis in vitro and in 
vivo [l&16]. Hence, newly developed inhibitors of this 
enzyme could prove to be potent antitumoral agents. 
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